Affimed N.V. Gains 227.85%

Fri, May 16, 2025 at 06:53 PM

Affimed N.V. (AFMD:NASDAQ) soared at $0.28, representing a gain of 227.8%. The stock got featured on our News Catalysts scanner on Wed, May 14, 2025 at 08:41 AM in the 'INVESTOR UPDATE' category. From Fri, May 02, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days

About Affimed N.V. (AFMD:NASDAQ)

Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology to fight tumor cells.

Top 10 Gainers:

Affimed N.V. (AFMD:NASDAQ), 227.85%
Inozyme Pharma, Inc. (INZY:NASDAQ), 178.17%
Hempacco Co., Inc. (HPCO:NASDAQ), 87.5%
Siyata Mobile Inc. (SYTA:NASDAQ), 75%
DeFi Development Corp. (DFDV:NASDAQ), 74.45%
Amesite Inc. (AMST:NASDAQ), 50%
NWTN Inc. (NWTN:NASDAQ), 48.41%
Virgin Galactic Holdings, Inc. (SPCE:NYSE), 43.28%
Biodesix, Inc. (BDSX:NASDAQ), 36.91%
Agape ATP Corporation (ATPC:NASDAQ), 36.67%